Cargando…
Targeting cardiac hypertrophy through a nuclear co‐repressor
Heart failure entails the inability of the heart to pump blood to vital organs. One of the main risk factors for heart failure is the development of pathological hypertrophy. In this issue of EMBO Molecular Medicine, Li and coworkers show that NCoR1, a co‐repressor of transcription factors, inhibits...
Autores principales: | Grund, Andrea, Heineke, Joerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835198/ https://www.ncbi.nlm.nih.gov/pubmed/31622030 http://dx.doi.org/10.15252/emmm.201911297 |
Ejemplares similares
-
A NFAT decoy approach to inhibit cardiac hypertrophy
por: Heineke, Joerg
Publicado: (2021) -
Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy
por: Eitner, Fiona, et al.
Publicado: (2022) -
Sodium leak through K2P potassium channels and cardiac arrhythmia, an emerging theme
por: Goldstein, Steve AN
Publicado: (2017) -
Recent insights into Groucho co-repressor recruitment and function
por: Kaul, Aamna K, et al.
Publicado: (2015) -
Co‐targeting driver pathways in prostate cancer: two birds with one stone
por: Zoubeidi, Amina, et al.
Publicado: (2018)